The U.S. Food and Drug Administration has approved the first totally implanted hearing system.
The FDA said the Esteem System is designed to treat moderate to severe sensorineural hearing loss, a type of permanent hearing loss usually caused by genetic factors or damage to the inner ear resulting from noise, viral infections or aging. Such a loss of hearing produces reductions in the perception of sounds and in the ability to understand speech.
Sensorineural hearing loss differs from conductive hearing loss, which occurs when sound waves cannot transmit well through the outer or middle ear or both, the FDA says, noting medical or surgical treatment can often restore hearing in people with a conductive hearing loss, which can be caused by earwax, fluid in the middle ear space or a punctured eardrum.
"The approval of Esteem provides patients with an option to alleviate their hearing loss by using a device with no readily visible external components," says Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health.
The system, manufactured by the Envoy Medical Corp. of St. Paul, MN, is designed to alleviate the effects of hearing loss in patients ages 18 years and older.
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025